Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$0.74 - $1.83 $185 - $457
-250 Reduced 50.0%
250 $0
Q1 2022

Jul 14, 2022

BUY
$2.0 - $4.9 $1,000 - $2,450
500 New
500 $1,000
Q4 2021

Jan 21, 2022

SELL
$4.65 - $7.23 $3,952 - $6,145
-850 Closed
0 $0
Q1 2021

Apr 14, 2021

SELL
$7.03 - $16.51 $7 - $16
-1 Reduced 0.12%
850 $7,000
Q4 2020

Jan 13, 2021

SELL
$5.76 - $11.95 $8,985 - $18,642
-1,560 Reduced 64.7%
851 $6,000
Q3 2020

Oct 09, 2020

BUY
$6.17 - $18.82 $9,322 - $28,437
1,511 Added 167.89%
2,411 $27,000
Q2 2020

Jul 13, 2020

BUY
$1.73 - $6.76 $1,557 - $6,084
900 New
900 $6,000

Others Institutions Holding SRNE

About Sorrento Therapeutics, Inc.


  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Global Retirement Partners, LLC Portfolio

Follow Global Retirement Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Retirement Partners, LLC with notifications on news.